 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - NeuroBo Pharmaceuticals Inc. (NRBO)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-03-10 Purchase | 2017-03-14 5:33 pm | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director | 52,798 | $9.47 | $499,997 | 858,823 (Indirect) | View |
| 2017-03-10 Purchase | 2017-03-14 5:46 pm | Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director | 25,000 | $9.47 | $236,750 | 81,889 (Indirect Direct) | View |
| 2017-03-10 Purchase | 2017-03-14 5:57 pm | Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director | 10,559 | $9.47 | $99,994 | 59,833 (Direct) | View |
| 2017-03-10 Purchase | 2017-03-14 6:07 pm | Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director | 21,119 | $9.47 | $199,997 | 136,264 (Direct) | View |
| 2018-02-08 Purchase | 2018-02-12 4:31 pm | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 71,429 | $7 | $500,003 | 930,252 (Indirect) | View |
| 2018-02-08 Purchase | 2018-02-12 4:40 pm | Gemphire Therapeutics Inc. | GEMP | Reno Seth Chief Commercial Officer | 14,286 | $7 | $100,002 | 18,286 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-03-10 Purchase | 2017-03-14 5:33 pm | 2017-03-10 2022-03-15 | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director | 39,599 | $9.47 | 858,823 (Indirect) | View |
| 2017-03-10 Purchase | 2017-03-14 5:46 pm | 2017-03-10 2022-03-15 | Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director | 18,750 | $9.47 | 81,889 (Indirect) | View |
| 2017-03-10 Purchase | 2017-03-14 5:57 pm | 2017-03-10 2022-03-15 | Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director | 7,920 | $9.47 | 59,833 (Direct) | View |
| 2017-03-10 Purchase | 2017-03-14 6:07 pm | 2017-03-10 2022-03-15 | Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director | 15,840 | $9.47 | 136,264 (Direct) | View |
| 2017-03-28 Option Award | 2017-03-29 4:17 pm | N/A 2027-03-27 | Gemphire Therapeutics Inc. | GEMP | Golden Lee Scott Chief Medical Officer | 20,000 | $11.15 | 20,000 (Direct) | View |
| 2017-05-30 Option Award | 2017-05-31 4:25 pm | N/A 2027-05-29 | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 60,000 | $10.26 | 60,000 (Direct) | View |
| 2017-07-31 Exercise | 2017-08-02 4:11 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chairman Chief Scientific Off. & Chair 10% Owner | 4,474 | $1.344 | 0 (Direct) | View |
| 2017-07-31 Exercise | 2017-08-02 4:11 pm | 2015-06-29 2025-06-28 | Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chairman Chief Scientific Off. & Chair 10% Owner | 4,474 | $1.344 | 0 (Direct) | View |
| 2017-08-10 Exercise | 2017-08-11 4:07 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 3,000 | $3.59 | 0 (Direct) | View |
| 2017-08-10 Exercise | 2017-08-11 4:07 pm | 2015-09-25 2025-09-24 | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 3,000 | $3.59 | 0 (Direct) | View |
| 2017-08-10 Exercise | 2017-08-15 4:22 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 3,000 | $3.59 | 45,093 (Direct) | View |
| 2017-08-10 Exercise | 2017-08-15 4:22 pm | 2015-09-25 2025-09-24 | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 3,000 | $3.59 | 45,093 (Direct) | View |
| 2017-08-14 Exercise | 2017-08-16 4:10 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 3,207 | $3.59 | 0 (Direct) | View |
| 2017-08-14 Exercise | 2017-08-16 4:10 pm | 2015-09-25 2025-09-24 | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 3,207 | $3.59 | 0 (Direct) | View |
| 2018-01-29 Option Award | 2018-01-30 4:06 pm | N/A 2028-01-28 | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 60,000 | $10.44 | 60,000 (Direct) | View |
| 2018-01-28 Option Award | 2018-01-30 4:13 pm | N/A 2028-01-27 | Gemphire Therapeutics Inc. | GEMP | Reno Seth Chief Commercial Officer | 48,000 | $10.1 | 48,000 (Direct) | View |
| 2018-01-28 Option Award | 2018-01-30 4:20 pm | N/A 2028-01-27 | Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S CFO | 48,000 | $10.1 | 48,000 (Direct) | View |
| 2018-01-28 Option Award | 2018-01-30 4:27 pm | N/A 2028-01-27 | Gemphire Therapeutics Inc. | GEMP | Golden Lee Scott Chief Medical Officer | 148,000 | $10.1 | 148,000 (Direct) | View |
| 2018-01-28 Option Award | 2018-01-30 4:36 pm | N/A 2028-01-27 | Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chairman Chief Scien Officer & Chair 10% Owner | 48,000 | $10.1 | 48,000 (Direct) | View |
| 2018-01-29 Option Award | 2018-01-30 4:44 pm | N/A 2028-01-28 | Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director | 10,800 | $10.44 | 10,800 (Direct) | View |
| 2018-01-29 Option Award | 2018-01-30 4:52 pm | N/A 2028-01-28 | Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director | 10,800 | $10.44 | 10,800 (Direct) | View |
| 2018-01-29 Option Award | 2018-01-30 5:04 pm | N/A 2028-01-28 | Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director | 10,800 | $10.44 | 10,800 (Direct) | View |
| 2018-01-29 Option Award | 2018-01-30 5:12 pm | N/A 2028-01-28 | Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director | 10,800 | $10.44 | 10,800 (Direct) | View |
| 2018-05-01 Option Award | 2018-05-03 4:32 pm | N/A 2028-04-30 | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 150,000 | $5.56 | 150,000 (Direct) | View |
| 2018-05-22 Option Award | 2018-05-24 4:31 pm | N/A 2028-04-30 | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 50,000 | $5.56 | 50,000 (Direct) | View |
| 2018-05-22 Option Award | 2018-05-24 4:31 pm | N/A 2028-04-30 | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 50,000 | $5.56 | 50,000 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-26 4:01 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-26 4:10 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chairman Chief Scientific Off. & Chair 10% Owner | 100,000 | $0 | 1,348,914 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-26 4:16 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | Reno Seth Chief Commercial Officer | 100,000 | $0 | 118,286 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-26 4:24 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director | 15,000 | $0 | 26,935 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-26 4:30 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director | 15,000 | $0 | 74,833 (Direct) | View |
| 2019-07-24 Option Award | 2019-07-26 4:38 pm | N/A N/A | Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director | 15,000 | $0 | 151,264 (Direct) | View |
| 2019-12-30 Option Award | 2020-01-02 9:52 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 4,335,800 | $0 | 1,864,799 (Indirect) | View |
| 2019-12-30 Option Award | 2020-01-02 9:52 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 1,121,190 | $0 | 1,864,799 (Indirect) | View |
| 2019-12-30 Option Award | 2020-01-02 9:52 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 1,864,799 | $0 | 1,864,799 (Indirect) | View |
| 2019-12-30 Option Award | 2020-01-02 9:53 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Oh Jeong Gyun Director 10% Owner | 1,817,842 | $0 | 240,051 (Indirect) | View |
| 2019-12-30 Option Award | 2020-01-02 9:53 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Oh Jeong Gyun Director 10% Owner | 240,051 | $0 | 240,051 (Indirect) | View |
| 2019-12-30 Option Award | 2020-01-02 9:54 pm | N/A 2029-01-28 | NeuroBo Pharmaceuticals Inc. | NRBO | Versavel Mark Chief Medical Officer | 297,206 | $0.63 | 45,724 (Direct) | View |
| 2019-12-30 Option Award | 2020-01-02 9:54 pm | N/A 2029-01-31 | NeuroBo Pharmaceuticals Inc. | NRBO | Versavel Mark Chief Medical Officer | 45,724 | $0.63 | 45,724 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:10 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | GROVES JASON L Director | 60,000 | $8.39 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:11 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Gullans Steven R. Ph.D. Director | 60,000 | $8.39 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:12 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Jeong Tae Heum Director | 60,000 | $8.39 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:13 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Kim Na Yeon Director 10% Owner | 60,000 | $8.39 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:15 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Oh Jeong Gyun Director 10% Owner | 60,000 | $8.39 | 60,000 (Direct) | View |
| 2020-01-13 Option Award | 2020-01-15 7:16 pm | N/A 2030-01-12 | NeuroBo Pharmaceuticals Inc. | NRBO | Salsbury Michael Director | 60,000 | $8.39 | 60,000 (Direct) | View |
| 2020-09-01 Option Award | 2020-09-03 6:48 pm | N/A 2030-09-01 | NeuroBo Pharmaceuticals Inc. | NRBO | Swirsky Douglas J Director | 60,000 | $6.04 | 60,000 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 4:09 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Bakshi Akash COO | 29,013 | $0 | 884,072 (Direct) | View |
| 2020-12-31 Option Award | 2021-01-05 4:09 pm | N/A N/A | NeuroBo Pharmaceuticals Inc. | NRBO | Bakshi Akash COO | 855,059 | $0 | 884,072 (Indirect) | View |